SightfileU.S. market data from official filings

ASCENDIS PHARMA A/S SPONSORED (ASND)

Name: ASCENDIS PHARMA A/S SPONSORED (ASND) — Institutional ownership, SEC filings and insider activity
Creator: Sightfile
License: https://www.sec.gov/privacy#dissemination

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001612042 · EDGAR filings · Updated 2026-07-15

ASCENDIS PHARMA A/S SPONSORED (ASND) has reported institutional ownership of 88.3%, with 264 institutional managers holding positions valued at $12.5B per the latest 13F reporting period.

Institutional ownership

88.3%

Institutional managers

264

Reported 13F value

$12.5B

Latest updates

2026-07-15 — Foreign issuer report (6-K) filed
2026-06-30 — Foreign issuer report (6-K) filed
2026-06-29 — Foreign issuer report (6-K) filed
2026-06-17 — Foreign issuer report (6-K) filed
2026-06-15 — Foreign issuer report (6-K) filed
2026-06-12 — Foreign issuer report (6-K) filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, ASCENDIS PHARMA A/S SPONSORED has 264 institutional holders and institutional ownership of 88.3%.

Insider activity

Insiders reported 0 transactions (0 buys, 0 sells) across 12 reporting insiders, with a net reported value of $0.

Related companies

ELANCO ANIMAL HEALTH INC (ELAN) · IONIS PHARMACEUTICALS INC (IONS) · GUARDANT HEALTH INC (GH) · MADRIGAL PHARMACEUTICALS INC (MDGL) · JAZZ PHARMACEUTICALS PLC (JAZZ) · ALIGN TECHNOLOGY INC (ALGN)

See full history, cross-references and alerts on Sightfile

Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-15.